A Single-center, Open-label Positron Emission Tomography Study to Evaluate the Time-course of Displacement of [11C]UCB-J by Brivaracetam and Levetiracetam in Healthy Volunteers

Trial Profile

A Single-center, Open-label Positron Emission Tomography Study to Evaluate the Time-course of Displacement of [11C]UCB-J by Brivaracetam and Levetiracetam in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Nov 2017

At a glance

  • Drugs Brivaracetam (Primary) ; Levetiracetam (Primary)
  • Indications Epilepsy
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 27 Oct 2017 Status changed from recruiting to completed.
    • 11 May 2017 Status changed from completed to recruiting.
    • 28 Apr 2017 Results comparing the entrance rate of brivaracetam with levetiracetam presented at the 69th Annual Meeting of the American Academy of Neurology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top